activity Member
2022 - Presentactivity Director
2022 - Presentactivity Abstract Reviewer
07/01/2023 - Presentactivity Reviewer
10/01/2015 - Presentactivity Reviewer
10/01/2015 - Presentactivity Reviewer
10/01/2017 - Presentactivity Reviewer
10/01/2021 - Presentactivity Co-Director
2023 - Presentactivity Member
2022 - Presentactivity Reviewing Editor
2019 - Presentactivity Reviewer
2023 - Presentactivity Member
2014 - Presentactivity Member
2014 - Presentactivity : Clinical Correlates of Response with Mogamulizumab in MF/SS: Skin Flare and Lymphopenia
activity Efficacy and Safety of EPOCH in Aggressive T-Cell Lymphomas- A Real World Analysis
activity T-Cell Lymphoma Case Presentation
activity Efficacy and Safety of EPOCH in Aggressive Presentations of Cutaneous T-Cell Lymphomas
activity Moderator
2021 - 2021DescriptionSession Name: 624. Hodgkin Lymphomas and T/NK cell Lymphomas: T/NK Cell Lymphoma Relapsed Therapy Session Date: Monday, December 13, 2021 Session Time: 10:30 AM - 12:00 PM Eastern time Room: Georgia World Congress Center, Hall A1activity Advances in Treatment of Primary Central Nervous System Lymphoma
activity Beyond Chemotherapy: Novel Approach to Treatment of Primary Central Nervous System Lymphoma